MedPath
NMPA Approval

Travoprost Eye Drops

国药准字H20249647

December 1, 2024

Drug Information

曲伏前列素滴眼液

眼用制剂

0.004%(2.5ml:0.1mg)

化学药品

December 1, 2024

Company Information

Applicant Company

广州市南沙区珠江工业园美德三路1号自编A区5层501房

Manufacturing Company

广州市南沙区珠江工业园美德三路1号自编B栋5楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.